FARM5170 – Drugs for treatment of degenerative and life style diseases
Course description
Course content
The course is based on lower level pharmacology courses and will provide in-depth understanding of drug treatment of neurodegenerative diseases, degenerative bone diseases (osteoporosis, arthrosis), chronic obstructive pulmonary disease (COPD), type 2 diabetes and obesity. The course will provide advanced knowledge on current drug treatments and possible future drug treatments for various patient groups, including children and elderly. The course also includes "biological" drugs, polypharmaceuticals, diagnostics, new biomarkers, and societal aspects of pharmaceuticals such as pharmacoeconomics and use of individual health registries and databases (big data) for pharmacoepidemiological studies.
Learning outcome
After completing the course:
- you have in depth knowledge about pathophysiology of the mentioned disease groups / conditions.
- you have broad knowledge and can communicate present drug therapy and possible future drug treatments for health professionals and different patient groups, both for children and elderly.
- you have knowledge of diagnostic methods and identification of new biomarkers to identify preventative and therapeutic measures and to monitor the effect of various medical interventions.
- you can identify problems related to the use of several drugs at the same time (polypharmacy) such as drug interactions.
- you can appraise important societal aspects of drug treatments including efficacy and safety at the individual and community level, with a focus on both children and the elderly, as well as drug priorities in the health service.
Admission to the course
The course is mainly open to students who have been admitted to the 5-year Master`s Programme in Pharmacy at the Department?of Pharmacy, University of Oslo. In the event that space is available, other master`s level students may apply. Knowledge in relevant subject area corresponding to the content of Semester 1 through 7 at the department’s Master`s Programme in Pharmacy is required. For more information, please contact the Study Administration at the Department of Pharmacy, studieinfo@farmasi.uio.no.
Formal prerequisite knowledge
Passed the exam in:
- FARM1100 – Pharmaceutical Chemistry
- FARM1110 – Pharmacology, Physiology and Cell Biology 1
- FARM1120 – Social Pharmacy
- FARM1130 – Pharmaceutically Based Organic Chemistry
- FARM1140 – Pharmacology, Physiology and Cell Biology 2
- FARM1150 – Pharmaceutical Based Biochemistry
- FARM2100 – Medicinal Chemistry
- FARM2110 – Pharmacotherapy 1
- FARM2120 – Pharmaceutics and Biopharmaceutics
- FARM2130 – Pharmaceutical Analytical Chemistry
- FARM2140 – Pharmaceutical Microbiology
- FARM2150 – Formulation of Drugs and Quality Assurance in Drug Production
- FARM3100 – Pharmacognosy
- FARM3110 – Pharmacotherapy 2
- FARM3120 – Medicine Use and Public Health
- FARM3130 – Advanced Pharmacy Practice Experience (APPE)
- the compulsory HMS-courses HMS0501 – Safety and Physical Environment, HMS0502 – Positive Learning Environment, HMS0503 – Laboratory Safety, HMS0506 – Patient Clinic Safety and HMS0507 – Fire Safety required for students at the 5-year Master`s Programme in Pharmacy.
Approved the compulsory parts of:
- FARM4100 – Personalised Drug Therapy
- FARM4110 – Comprehensive Biopharmacy and Formulation Technology
- FARM4120 – Drug Development
Formal prerequisite knowledge for students admitted to Studiel?p for farmas?yter med mastergrad fra land utenfor EU/E?S:
- FARM4910K – Farmakoterapi og samfunnsfarmasi med fokus p? norske terapitradisjoner og norske forhold
- FARM4920K – Fra virkestoff til ferdig formulering med fokus p? avanserte legemiddelformer
- FARM4930K – Kvalitetssikring ved produksjon og klinisk utpr?vning av legemidler
- approved the compulsory HMS-courses HMS0501 – Safety and Physical Environment, HMS0502 – Positive Learning Environment, HMS0503 – Laboratory Safety, HMS0506 – Patient Clinic Safety and HMS0507 – Fire Safety required for students at the 5-year Master`s Programme in Pharmacy.
For students admitted to the 5-year Master`s Programme in Pharmacy until and including 2016 and who have been transferred from the old study plan, separate formal prerequisite knowledge apply. These are in professional compliance with the formal prerequisite knowledge that apply to the course, but may be replaced by courses from the old study plan, as well as transitional courses. Students on transitional arrangements may contact the study administration for a complete overview of the formal prerequisite knowledge required.
Overlapping courses
- 5 credits overlap with FRM5710 – Pharmacology, graduate level (discontinued).
- 5 credits overlap with FRM9710 – Pharmacology, graduate level (discontinued).
Teaching
Each topic runs over two weeks. The first day of each topic period includes introductory lecture(s), students are divided into groups and assignments are given for group work (1-2 hours). On the next day of the topic period, the theme ends with student-driven discussions / review and summary of the assignments / theme in plenary (1-2 hours).
Approximately?29 teaching hours in total.
The course may be cancelled if the number of enrolled students are low.
Examination
Final written exam, which counts 100?% towards the finale grade.?
Examination support material
No examination support material is allowed.
Language of examination
The examination text is given in Norwegian. You may submit your response in Norwegian, Swedish or Danish. English on request.
Grading scale
Grades are awarded on a scale from A to F, where A is the best grade and F?is a fail. Read more about the grading system.
Resit an examination
This course offers both postponed and resit of examination. Read more:
More about examinations at UiO
- Use of sources and citations
- Special exam arrangements due to individual needs
- Withdrawal from an exam
- Illness at exams / postponed exams
- Explanation of grades and appeals
- Resitting an exam
- Cheating/attempted cheating
You will find further guides and resources at the web page on examinations at UiO.